{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T11:40:49Z","timestamp":1784115649078,"version":"3.55.0"},"reference-count":136,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.ijbiomac.2021.01.042","type":"journal-article","created":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T01:17:21Z","timestamp":1610327841000},"page":"93-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Tantalizing role of p53 molecular pathways and its coherent medications in neurodegenerative diseases"],"prefix":"10.1016","volume":"172","author":[{"given":"Marjan","family":"Talebi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Talebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Kakouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahereh","family":"Farkhondeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Mohammad","family":"Pourbagher-Shahri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros A.","family":"Tarantilis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Samarghandian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2021.01.042_bb0005","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.pneurobio.2013.08.003","article-title":"A review of quality of life after predictive testing for and earlier identification of neurodegenerative diseases","volume":"110","author":"Paulsen","year":"2013","journal-title":"Prog. Neurobiol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2021.01.042_bb0010","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028035","article-title":"Pathology of neurodegenerative diseases","volume":"9","author":"Dugger","year":"2017","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.ijbiomac.2021.01.042_bb0015","series-title":"Neurodegenerative Disorders as Systemic Diseases","first-page":"183","article-title":"Drug development for neurodegenerative diseases","author":"Nagai","year":"2015"},{"issue":"10","key":"10.1016\/j.ijbiomac.2021.01.042_bb0020","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","article-title":"Ageing as a risk factor for neurodegenerative disease","volume":"15","author":"Hou","year":"2019","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.01.042_bb0025","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.pharmthera.2013.11.009","article-title":"p53 in neurodegenerative diseases and brain cancers","volume":"142","author":"Checler","year":"2014","journal-title":"Pharmacol. Ther."},{"issue":"10","key":"10.1016\/j.ijbiomac.2021.01.042_bb0030","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/sj.cdd.4400736","article-title":"Neuronal life and death: an essential role for the p53 family","volume":"7","author":"Miller","year":"2000","journal-title":"Cell Death Differ."},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.01.042_bb0035","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrm2147","article-title":"p53 in health and disease","volume":"8","author":"Vousden","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.01.042_bb0040","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11515-011-0970-8","article-title":"Tumor suppressor p53: new functions of an old protein","volume":"6","author":"Feng","year":"2011","journal-title":"Frontiers of Biology in China."},{"issue":"5","key":"10.1016\/j.ijbiomac.2021.01.042_bb0045","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/acel.12646","article-title":"The emerging role of alternative splicing in senescence and aging","volume":"16","author":"Desch\u00eanes","year":"2017","journal-title":"Aging Cell"},{"key":"10.1016\/j.ijbiomac.2021.01.042_bb0050","first-page":"21(2)","article-title":"P53 and the immune response: 40 years of exploration-a plan for the future","volume":"15","author":"Levine","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.ijbiomac.2021.01.042_bb0055","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1039\/C8MD00273H","article-title":"Chemical modulation of transcription factors","volume":"9","author":"Wiedemann","year":"2018","journal-title":"MedChemComm."},{"issue":"10","key":"10.1016\/j.ijbiomac.2021.01.042_bb0060","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/sj.cdd.4400741","article-title":"The role of p53 in neuronal cell death","volume":"7","author":"Morrison","year":"2000","journal-title":"Cell Death Differ."},{"issue":"6","key":"10.1016\/j.ijbiomac.2021.01.042_bb0065","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/sj.cdd.4401910","article-title":"The P53 pathway: what questions remain to be explored?","volume":"13","author":"Levine","year":"2006","journal-title":"Cell Death Differ."},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.01.042_bb0070","doi-asserted-by":"crossref","first-page":"312","DOI":"10.4161\/cc.6.3.3795","article-title":"To die or not to die: neurons and p63","volume":"6","author":"Miller","year":"2007","journal-title":"Cell cycle (Georgetown, Tex)"},{"issue":"7","key":"10.1016\/j.ijbiomac.2021.01.042_bb0075","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1007\/s12035-015-9381-1","article-title":"How does p73 cause neuronal defects?","volume":"53","author":"Niklison-Chirou","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ijbiomac.2021.01.042_bb0080","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.pneurobio.2018.05.001","article-title":"The interactions of p53 with tau and A\u00df as potential therapeutic targets for Alzheimer's disease","volume":"168","author":"Jazvin\u0161\u0107ak Jembrek","year":"2018","journal-title":"Prog. Neurobiol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2021.01.042_bb0085","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/NEN.0b013e31816ff780","article-title":"DNA damage and repair: Relevance to mechanisms of neurodegeneration","volume":"67","author":"Martin","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.01.042_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/biom10030420","article-title":"Role of p53 in the regulation of cellular senescence","volume":"10","author":"Mijit","year":"2020","journal-title":"Biomolecules"},{"issue":"9","key":"10.1016\/j.ijbiomac.2021.01.042_bb0095","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1038\/cdd.2016.37","article-title":"p53 isoforms regulate astrocyte-mediated neuroprotection and neurodegeneration","volume":"23","author":"Turnquist","year":"2016","journal-title":"Cell Death Differ."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.01.042_bb0100","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.3390\/ijms16022879","article-title":"BRCA1 and p53 tumor suppressor molecules in Alzheimer's disease","volume":"16","author":"Nakanishi","year":"2015","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.01.042_bb0105","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000329999","article-title":"Role of p53 in neurodegenerative diseases","volume":"9","author":"Chang","year":"2012","journal-title":"Neurodegener. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.ijbiomac.2021.01.042_bb0110","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1038\/onc.2009.45","article-title":"PUMA, a potent killer with or without p53","volume":"27","author":"Yu","year":"2008","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.01.042_bb0115","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1124\/jpet.112.192138","article-title":"Mitochondrial dysfunction in neurodegenerative diseases","volume":"342","author":"Johri","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"53","key":"10.1016\/j.ijbiomac.2021.01.042_bb0120","doi-asserted-by":"crossref","first-page":"7644","DOI":"10.1038\/sj.onc.1203015","article-title":"Regulation of p53 in response to DNA damage","volume":"18","author":"Lakin","year":"1999","journal-title":"Oncogene"},{"issue":"21","key":"10.1016\/j.ijbiomac.2021.01.042_bb0125","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.2174\/092986709788681976","article-title":"p53-Induced apoptosis and inhibitors of p53","volume":"16","author":"Nayak","year":"2009","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.01.042_bb0130","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.freeradbiomed.2007.09.001","article-title":"Neurotoxicity from glutathione depletion is mediated by Cu-dependent p53 activation","volume":"44","author":"Du","year":"2008","journal-title":"Free Radic. Biol. Med."},{"issue":"12","key":"10.1016\/j.ijbiomac.2021.01.042_bb0135","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18122753","article-title":"Sulfuretin attenuates MPP+-induced neurotoxicity through Akt\/GSK3\u03b2 and ERK signaling pathways","volume":"18","author":"Pariyar","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.ijbiomac.2021.01.042_bb0140","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron."},{"issue":"12","key":"10.1016\/j.ijbiomac.2021.01.042_bb0145","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1080\/01616412.2016.1249997","article-title":"Role of neuroinflammation and latent transcription factors in pathogenesis of Parkinson's disease","volume":"38","author":"Pal","year":"2016","journal-title":"Neurol. Res."},{"issue":"5","key":"10.1016\/j.ijbiomac.2021.01.042_bb0150","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41582-020-0348-0","article-title":"An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders","volume":"16","author":"Ashton","year":"2020","journal-title":"Nat. Rev. Neurol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2021.01.042_bb0155","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/jnc.13706","article-title":"Dopaminergic neuron-specific deletion of p53 gene is neuroprotective in an experimental Parkinson's disease model","volume":"138","author":"Qi","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ijbiomac.2021.01.042_bb0160","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13024-016-0079-2","article-title":"Direct \u03b1-synuclein promoter transactivation by the tumor suppressor p53","volume":"11","author":"Duplan","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ijbiomac.2021.01.042_bb0165","first-page":"2(8)","article-title":"Programmed cell death in Parkinson's disease","volume":"1","author":"Venderova","year":"2012","journal-title":"Cold Spring Harbor Perspectives in Medicine."},{"issue":"11","key":"10.1016\/j.ijbiomac.2021.01.042_bb0170","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ncb1981","article-title":"Transcriptional repression of p53 by parkin and impairment by mutations associated with autosomal recessive juvenile Parkinson's disease","volume":"11","author":"da Costa","year":"2009","journal-title":"Nat. Cell Biol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2021.01.042_bb0175","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/cns.12078","article-title":"The beneficial role of thiamine in Parkinson disease","volume":"19","author":"Luong","year":"2013","journal-title":"CNS Neuroscience & Therapeutics."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.01.042_bb0180","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.cell.2016.05.039","article-title":"Parkinson's disease-related PROTEINS PINK1 and parkin repress mitochondrial antigen presentation","volume":"166","author":"Matheoud","year":"2016","journal-title":"Cell."},{"issue":"5","key":"10.1016\/j.ijbiomac.2021.01.042_bb0185","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/sj.cdd.4402084","article-title":"Essential postmitochondrial function of p53 uncovered in DNA damage-induced apoptosis in neurons","volume":"14","author":"Vaughn","year":"2007","journal-title":"Cell Death Differ."},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.01.042_bb0190","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nrn1886","article-title":"Ageing and neuronal vulnerability","volume":"7","author":"Mattson","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.01.042_bb0195","doi-asserted-by":"crossref","first-page":"103","DOI":"10.5607\/en.2015.24.2.103","article-title":"Mitochondrial dysfunction in Parkinson's disease","volume":"24","author":"Moon","year":"2015","journal-title":"Exp. Neurobiol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2021.01.042_bb0200","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/onc.2011.268","article-title":"Consequences of DJ-1 upregulation following p53 loss and cell transformation","volume":"31","author":"Vasseur","year":"2012","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.ijbiomac.2021.01.042_bb0205","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/jcm8091377","article-title":"DJ-1 in Parkinson's disease: clinical insights and therapeutic perspectives","volume":"8","author":"Repici","year":"2019","journal-title":"J. Clin. Med."},{"issue":"5","key":"10.1016\/j.ijbiomac.2021.01.042_bb0210","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.bbamcr.2019.02.009","article-title":"Mechanical insights into the regulation of programmed cell death by p53 via mitochondria","volume":"1866","author":"Yamada","year":"2019","journal-title":"Biochim. Biophys. Acta, Mol. Cell Res."},{"issue":"6","key":"10.1016\/j.ijbiomac.2021.01.042_bb0215","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.cell.2020.08.004","article-title":"The in situ structure of Parkinson's disease-linked LRRK2","volume":"182","author":"Watanabe","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2021.01.042_bb0220","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13041-015-0145-7","article-title":"Leucine-Rich Repeat Kinase 2 (LRRK2) phosphorylates p53 and induces p21(WAF1\/CIP1) expression","volume":"8","author":"Ho","year":"2015","journal-title":"Molecular Brain"},{"issue":"10","key":"10.1016\/j.ijbiomac.2021.01.042_bb0225","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s12272-017-0960-8","article-title":"Neuroprotective strategies to prevent and treat Parkinson's disease based on its pathophysiological mechanism","volume":"40","author":"Lee","year":"2017","journal-title":"Arch. Pharm. Res."},{"issue":"19","key":"10.1016\/j.ijbiomac.2021.01.042_bb0230","doi-asserted-by":"crossref","first-page":"8161","DOI":"10.1073\/pnas.0609874104","article-title":"Two molecular pathways initiate mitochondria-dependent dopaminergic neurodegeneration in experimental Parkinson's disease","volume":"104","author":"Perier","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.01.042_bb0235","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3892\/ijmm.2015.2430","article-title":"Damage to dopaminergic neurons is mediated by proliferating cell nuclear antigen through the p53 pathway under conditions of oxidative stress in a cell model of Parkinson's disease","volume":"37","author":"Li","year":"2016","journal-title":"Int. J. Mol. Med."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.01.042_bb0240","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s12640-019-00050-w","article-title":"Pifithrin-alpha reduces methamphetamine neurotoxicity in cultured dopaminergic neurons","volume":"36","author":"Chen","year":"2019","journal-title":"Neurotox. Res."},{"issue":"10","key":"10.1016\/j.ijbiomac.2021.01.042_bb0245","doi-asserted-by":"crossref","first-page":"6849","DOI":"10.1007\/s12035-015-9577-4","article-title":"Ibuprofen abates cypermethrin-induced expression of pro-inflammatory mediators and mitogen-activated protein kinases and averts the nigrostriatal dopaminergic neurodegeneration","volume":"53","author":"Singh","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ijbiomac.2021.01.042_bb0250","doi-asserted-by":"crossref","first-page":"778","DOI":"10.3389\/fnins.2018.00778","article-title":"Sirtuins in neuroendocrine regulation and neurological diseases","volume":"12","author":"Fujita","year":"2018","journal-title":"Front. Neurosci."},{"issue":"6","key":"10.1016\/j.ijbiomac.2021.01.042_bb0255","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.250","article-title":"P7C3 inhibits GSK3\u03b2 activation to protect dopaminergic neurons against neurotoxin-induced cell death in vitro and in vivo","volume":"8","author":"Gu","year":"2017","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.ijbiomac.2021.01.042_bb0260","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.3892\/mmr.2014.2080","article-title":"Association of glycogen synthase kinase-3\u03b2 with Parkinson's disease (review)","volume":"9","author":"Li","year":"2014","journal-title":"Mol. Med. Rep."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.01.042_bb0265","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3109\/13880209.2012.716852","article-title":"Neuroprotective effects of luteolin against apoptosis induced by 6-hydroxydopamine on rat pheochromocytoma PC12 cells","volume":"51","author":"Guo","year":"2013","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.ijbiomac.2021.01.042_bb0270","first-page":"18(6)","article-title":"Protective effect of fucoidan against MPP(+)-induced SH-SY5Y cells apoptosis by affecting the PI3K\/Akt pathway","volume":"25","author":"Liu","year":"2020","journal-title":"Marine Drugs."},{"issue":"7","key":"10.1016\/j.ijbiomac.2021.01.042_bb0275","doi-asserted-by":"crossref","DOI":"10.3390\/nu11071655","article-title":"Effect of vasicinone against paraquat-induced mapk\/p53-mediated apoptosis via the igf-1r\/pi3k\/akt pathway in a Parkinson's disease-associated sh-sy5y cell model","volume":"11","author":"Ju","year":"2019","journal-title":"Nutrients"},{"issue":"11","key":"10.1016\/j.ijbiomac.2021.01.042_bb0280","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/aps.2011.119","article-title":"Protective effect of Bu-7, a flavonoid extracted from Clausena lansium, against rotenone injury in PC12 cells","volume":"32","author":"Li","year":"2011","journal-title":"Acta Pharmacol. Sin."},{"issue":"5","key":"10.1016\/j.ijbiomac.2021.01.042_bb0285","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.3892\/mmr.2016.5754","article-title":"\u03b1-Lipoic acid exerts neuroprotective effects on neuronal cells by upregulating the expression of PCNA via the P53 pathway in neurodegenerative conditions","volume":"14","author":"Li","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.01.042_bb0290","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.bbrc.2015.03.105","article-title":"p53 signalling mediates acupuncture-induced neuroprotection in Parkinson's disease","volume":"460","author":"Park","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.01.042_bb0295","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1007\/s12640-019-0004-x","article-title":"Effects of preventive treadmill exercise on the recovery of metabolic and mitochondrial factors in the 6-hydroxydopamine rat model of Parkinson's disease","volume":"35","author":"Rezaee","year":"2019","journal-title":"Neurotox. Res."},{"issue":"6","key":"10.1016\/j.ijbiomac.2021.01.042_bb0300","first-page":"7959","article-title":"Anti-oxidative and anti-apoptotic neuroprotective effects of Azadirachta indica in Parkinson-induced functional damage","volume":"17","author":"Xiang","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"7","key":"10.1016\/j.ijbiomac.2021.01.042_bb0305","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/jn\/nxaa128","article-title":"A-type cinnamon procyanidin oligomers protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice through inhibiting the P38 mitogen-activated protein kinase\/P53\/BCL-2 associated X protein signaling pathway","volume":"150","author":"Xu","year":"2020","journal-title":"J. Nutr."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.01.042_bb0310","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/ptr.6523","article-title":"Ferulic acid reinstates mitochondrial dynamics through PGC1\u03b1 expression modulation in 6-hydroxydopamine lesioned rats","volume":"34","author":"Anis","year":"2020","journal-title":"Phytotherapy Research: PTR."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.01.042_bb0315","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bbrc.2016.01.035","article-title":"Neuroprotective effect of sulfated polysaccharide isolated from sea cucumber Stichopus japonicus on 6-OHDA-induced death in SH-SY5Y through inhibition of MAPK and NF-\u03baB and activation of PI3K\/Akt signaling pathways","volume":"470","author":"Cui","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijbiomac.2021.01.042_bb0320","doi-asserted-by":"crossref","first-page":"919058","DOI":"10.1155\/2015\/919058","article-title":"Neuroprotective effects of alpha-mangostin on MPP(+)-induced apoptotic cell death in neuroblastoma SH-SY5Y cells","volume":"2015","author":"Janhom","year":"2015","journal-title":"Journal of Toxicology"},{"key":"10.1016\/j.ijbiomac.2021.01.042_bb0325","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1750-1172-5-40","article-title":"Huntington's disease: a clinical review","volume":"5","author":"Roos","year":"2010","journal-title":"Orphanet J Rare Dis."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.01.042_bb0330","doi-asserted-by":"crossref","first-page":"89","DOI":"10.59566\/IJBS.2011.7089","article-title":"Huntington's disease: from mutant huntingtin protein to neurotrophic factor therapy","volume":"7","author":"Sari","year":"2011","journal-title":"Int. J. Biomed. Sci."},{"issue":"12","key":"10.1016\/j.ijbiomac.2021.01.042_bb0335","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1073\/pnas.100110097","article-title":"The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription","volume":"97","author":"Steffan","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.01.042_bb0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.onc.1209021","article-title":"p53 tumor suppressor protein regulates the levels of huntingtin gene expression","volume":"25","author":"Feng","year":"2006","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.ijbiomac.2021.01.042_bb0345","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S1474-4422(05)70157-5","article-title":"Possible role for p53 in Huntington's disease","volume":"4","author":"Burton","year":"2005","journal-title":"The Lancet Neurology."},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.01.042_bb0350","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.bbrc.2014.04.129","article-title":"Modulation of mitochondrial function by stem cell-derived cellular components","volume":"448","author":"Liu","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"12","key":"10.1016\/j.ijbiomac.2021.01.042_bb0355","first-page":"2514","article-title":"Allele-specific regulation of mutant Huntingtin by Wig1, a downstream target of p53","volume":"25","author":"Kim","year":"2016","journal-title":"Hum. Mol. Genet."},{"issue":"35","key":"10.1016\/j.ijbiomac.2021.01.042_bb0360","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1038\/onc.2013.594","article-title":"Wig-1 regulates cell cycle arrest and cell death through the p53 targets FAS and 14-3-3\u03c3","volume":"33","author":"Bersani","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.ijbiomac.2021.01.042_bb0365","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.freeradbiomed.2013.04.016","article-title":"PGC-1\u03b1, mitochondrial dysfunction, and Huntington's disease","volume":"62","author":"Johri","year":"2013","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.01.042_bb0370","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","article-title":"Transcriptional repression of PGC-1 by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration","volume":"127","author":"Cui","year":"2006","journal-title":"Cell."},{"key":"10.1016\/j.ijbiomac.2021.01.042_bb0375","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3389\/fncel.2019.00103","article-title":"Mitochondrial dysfunction in Huntington's disease; interplay between HSF1, p53 and PGC-1\u03b1 transcription factors","volume":"13","author":"Intihar","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ijbiomac.2021.01.042_bb0380","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3389\/fncel.2019.00103","article-title":"Mitochondrial dysfunction in Huntington's disease; interplay between HSF1, p53 and PGC-1\u03b1 transcription factors","volume":"13","author":"Intihar","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ijbiomac.2021.01.042_bb0385","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.mcn.2017.12.009","article-title":"Perturbations in the p53\/miR-34a\/SIRT1 pathway in the R6\/2 Huntington's disease model","volume":"88","author":"Reynolds","year":"2018","journal-title":"Mol. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.01.042_bb0390","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13046-019-1059-5","article-title":"MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer","volume":"38","author":"Zhang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2021.01.042_bb0395","doi-asserted-by":"crossref","first-page":"118076","DOI":"10.1016\/j.lfs.2020.118076","article-title":"Dapagliflozin improves behavioral dysfunction of Huntington's disease in rats via inhibiting apoptosis-related glycolysis","volume":"10","author":"El-Sahar","year":"2020","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.01.042_bb0400","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4103\/1673-5374.175047","article-title":"How does resveratrol influence the genesis of some neurodegenerative diseases?","volume":"11","author":"Tellone","year":"2016","journal-title":"Neural Regen. Res."},{"issue":"6","key":"10.1016\/j.ijbiomac.2021.01.042_bb0405","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","article-title":"The hallmarks of aging","volume":"153","author":"L\u00f3pez-Ot\u00edn","year":"2013","journal-title":"Cell."},{"key":"10.1016\/j.ijbiomac.2021.01.042_bb0410","article-title":"A systematic review of preclinical and clinical studies on therapeutic potential of Piper nigrum on cognitive impairment in Alzheimer's disease and other biological conditions of memory loss","author":"Talebi","year":"2020","journal-title":"International Pharmacy Acta"},{"issue":"25","key":"10.1016\/j.ijbiomac.2021.01.042_bb0415","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.2174\/092986710791859324","article-title":"New therapeutic strategy for Parkinson's and Alzheimer's disease","volume":"17","author":"Esposito","year":"2010","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.01.042_bb0420","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1038\/s41467-020-15794-9","article-title":"Deletion of Topoisomerase 1 in excitatory neurons causes genomic instability and early onset neurodegeneration","volume":"11","author":"Fragola","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2021.01.042_bb0425","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.pneurobio.2013.10.004","article-title":"Autophagy and apoptosis dysfunction in neurodegenerative disorders","volume":"112","author":"Ghavami","year":"2014","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ijbiomac.2021.01.042_bb0430","doi-asserted-by":"crossref","first-page":"110590","DOI":"10.1016\/j.biopha.2020.110590","article-title":"Molecular mechanism-based therapeutic properties of honey","volume":"130","author":"Talebi","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.01.042_bb0435","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neulet.2007.03.026","article-title":"p53 is upregulated in Alzheimer's disease and induces tau phosphorylation in HEK293a cells","volume":"418","author":"Hooper","year":"2007","journal-title":"Neurosci. Lett."},{"issue":"Suppl. 4","key":"10.1016\/j.ijbiomac.2021.01.042_bb0440","first-page":"215","article-title":"Effects of p53 inhibitor on survival and death of cells subjected to oxidative stress","volume":"56","author":"Strosznajder","year":"2005","journal-title":"Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.01.042_bb0445","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41380-019-0500-7","article-title":"Three-dimensional modeling of human neurodegeneration: brain organoids coming of age","volume":"25","author":"Grenier","year":"2020","journal-title":"Mol. Psychiatry"},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.01.042_bb0450","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13125","article-title":"Increased miR-34c mediates synaptic deficits by targeting synaptotagmin 1 through ROS-JNK-p53 pathway in Alzheimer's Disease","volume":"19","author":"Shi","year":"2020","journal-title":"Aging Cell"},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.01.042_bb0455","doi-asserted-by":"crossref","first-page":"161","DOI":"10.5114\/fn.2017.68583","article-title":"Commitment of protein p53 and amyloid-beta peptide (A\u03b2) in aging of human cerebellum","volume":"55","author":"Ma\u015bli\u0144ska","year":"2017","journal-title":"Folia Neuropathol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2021.01.042_bb0460","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/sj.mp.4002060","article-title":"Conformationally altered p53: a novel Alzheimer's disease marker?","volume":"13","author":"Lanni","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ijbiomac.2021.01.042_bb0465","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1742-4933-5-7","article-title":"Alzheimer's disease: new diagnostic and therapeutic tools","volume":"5","author":"Racchi","year":"2008","journal-title":"Immunity & Ageing: I & A."},{"key":"10.1016\/j.ijbiomac.2021.01.042_bb0470","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3389\/fnagi.2017.00310","article-title":"PARP-1 and p53 regulate the increased susceptibility to oxidative death of lymphocytes from MCI and AD patients","volume":"9","author":"Salech","year":"2017","journal-title":"Front. Aging Neurosci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.01.042_bb0475","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.13","article-title":"Conformational altered p53 affects neuronal function: relevance for the response to toxic insult and growth-associated protein 43 expression","volume":"4","author":"Buizza","year":"2013","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.01.042_bb0480","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/acel.12335","article-title":"CHIP stabilizes amyloid precursor protein via proteasomal degradation and p53-mediated trans-repression of \u03b2-secretase","volume":"14","author":"Singh","year":"2015","journal-title":"Aging Cell"},{"issue":"9","key":"10.1016\/j.ijbiomac.2021.01.042_bb0485","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41419-020-02953-5","article-title":"CHIP as a therapeutic target for neurological diseases","volume":"11","author":"Zhang","year":"2020","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.01.042_bb0490","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s42003-020-0975-4","article-title":"Tau affects P53 function and cell fate during the DNA damage response","volume":"3","author":"Sola","year":"2020","journal-title":"Communications Biology"},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.01.042_bb0495","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s42003-020-0975-4","article-title":"Tau affects P53 function and cell fate during the DNA damage response","volume":"3","author":"Sola","year":"2020","journal-title":"Communications Biology"},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.01.042_bb0500","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s40478-020-01012-6","article-title":"P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer's disease","volume":"8","author":"Farmer","year":"2020","journal-title":"Acta Neuropathologica Communications"},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.01.042_bb0505","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10863-016-9669-5","article-title":"p53 and mitochondrial dysfunction: novel insight of neurodegenerative diseases","volume":"48","author":"Dai","year":"2016","journal-title":"J. Bioenerg. Biomembr."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.01.042_bb0510","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/sj.cdd.4400463","article-title":"Possible role of NF-\u03baB and p53 in the glutamate-induced pro-apoptotic neuronal pathway","volume":"6","author":"Grilli","year":"1999","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ijbiomac.2021.01.042_bb0515","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuropharm.2018.11.019","article-title":"Amyloid-\u00df promotes neurotoxicity by Cdk5-induced p53 stabilization","volume":"146","author":"Lapresa","year":"2019","journal-title":"Neuropharmacology."},{"issue":"7","key":"10.1016\/j.ijbiomac.2021.01.042_bb0520","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nm0798-835","article-title":"Inhibition of presenilin 1 expression is promoted by p53 and p21WAF-1and results in apoptosis and tumor suppression","volume":"4","author":"Roperch","year":"1998","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.01.042_bb0525","doi-asserted-by":"crossref","first-page":"25628","DOI":"10.1038\/srep25628","article-title":"p53-dependent SIRT6 expression protects A\u03b242-induced DNA damage","volume":"6","author":"Jung","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2021.01.042_bb0530","first-page":"340","article-title":"Melatonin regulates the aging mouse hippocampal homeostasis via the sirtuin1-FOXO1 pathway","volume":"16","author":"Jenwitheesuk","year":"2017","journal-title":"EXCLI J."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.01.042_bb0535","article-title":"Cofilin-mediated neuronal apoptosis via p53 translocation and PLD1 regulation","volume":"7","author":"Liu","year":"2017","journal-title":"Sci. Rep."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2021.01.042_bb0540","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mrfmmm.2010.12.017","article-title":"Icariin inhibits hydrogen peroxide-induced toxicity through inhibition of phosphorylation of JNK\/p38 MAPK and p53 activity","volume":"708","author":"Li","year":"2011","journal-title":"Mutat. Res."},{"key":"10.1016\/j.ijbiomac.2021.01.042_bb0545","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.steroids.2015.06.003","article-title":"Synthesis of novel steroidal curcumin derivatives as anti-Alzheimer's disease candidates: evidences-based on in vivo study","volume":"101","author":"Elmegeed","year":"2015","journal-title":"Steroids."},{"key":"10.1016\/j.ijbiomac.2021.01.042_bb0550","doi-asserted-by":"crossref","first-page":"8152373","DOI":"10.1155\/2018\/8152373","article-title":"Neuroprotective mechanisms of resveratrol in Alzheimer's disease: role of SIRT1","volume":"2018","author":"Gomes","year":"2018","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.ijbiomac.2021.01.042_bb0555","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.exger.2015.11.020","article-title":"Ameliorative effect of lotus seedpod proanthocyanidins on cognitive impairment and brain aging induced by D-galactose","volume":"74","author":"Gong","year":"2016","journal-title":"Exp. Gerontol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2021.01.042_bb0560","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/cmdc.201500422","article-title":"Nature-Inspired multifunctional ligands: focusing on amyloid-based molecular mechanisms of Alzheimer's disease","volume":"11","author":"Simoni","year":"2016","journal-title":"ChemMedChem."},{"key":"10.1016\/j.ijbiomac.2021.01.042_bb0565","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12979-018-0132-9","article-title":"Crocetin attenuates inflammation and amyloid-\u03b2 accumulation in APPsw transgenic mice","volume":"15","author":"Zhang","year":"2018","journal-title":"Immunity & Ageing: I & A."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.01.042_bb0570","article-title":"Association of Crocus sativus with cognitive dysfunctions and Alzheimer's disease: a systematic review","volume":"11","author":"Talebi","year":"2020","journal-title":"Biointerface Research in Applied Chemistry"},{"key":"10.1016\/j.ijbiomac.2021.01.042_bb0575","first-page":"9(8)","article-title":"Inhibitory effect of lycopene on amyloid-\u03b2-induced apoptosis in neuronal cells","volume":"16","author":"Hwang","year":"2017","journal-title":"Nutrients."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.01.042_bb0580","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/ana.22319","article-title":"Apomorphine treatment in Alzheimer mice promoting amyloid-\u03b2 degradation","volume":"69","author":"Himeno","year":"2011","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.01.042_bb0585","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/1533317516678086","article-title":"Effects of M2000 (D-mannuronic acid) on learning, memory retrieval, and associated determinants in a rat model of Alzheimer's disease","volume":"32","author":"Athari Nik Azm","year":"2017","journal-title":"Am. J. Alzheimers Dis. Other Dement."},{"key":"10.1016\/j.ijbiomac.2021.01.042_bb0590","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jep.2019.03.029","article-title":"Effect of Alpinia oxyphylla-Schisandra chinensis herb pair on inflammation and apoptosis in Alzheimer's disease mice model","volume":"237","author":"Qi","year":"2019","journal-title":"J. Ethnopharmacol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2021.01.042_bb0595","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1177\/1533317511432736","article-title":"Role of thiamine in Alzheimer's disease","volume":"26","author":"Lu'o'ng","year":"2011","journal-title":"Am. J. Alzheimers Dis. Other Dement."},{"key":"10.1016\/j.ijbiomac.2021.01.042_bb0600","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.6716","article-title":"A combination of curcumin, vorinostat and silibinin reverses A\u03b2-induced nerve cell toxicity via activation of AKT-MDM2-p53 pathway","volume":"7","author":"Meng","year":"2019","journal-title":"PeerJ."},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.01.042_bb0605","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s12035-013-8459-x","article-title":"Brain activation of SIRT1: role in neuropathology","volume":"48","author":"Para\u00edso","year":"2013","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.01.042_bb0610","doi-asserted-by":"crossref","first-page":"10105","DOI":"10.1038\/s41598-018-28366-1","article-title":"MicroRNA expression analysis identifies a subset of downregulated miRNAs in ALS motor neuron progenitors","volume":"8","author":"Rizzuti","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.01.042_bb0615","doi-asserted-by":"crossref","first-page":"8097","DOI":"10.1038\/s41598-018-26397-2","article-title":"TDP-43 induces p53-mediated cell death of cortical progenitors and immature neurons","volume":"8","author":"Vogt","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.01.042_bb0620","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/biomedicines7010014","article-title":"Mechanisms of neurodegeneration and axonal dysfunction in progressive multiple sclerosis","volume":"7","author":"Correale","year":"2019","journal-title":"Biomedicines"},{"key":"10.1016\/j.ijbiomac.2021.01.042_bb0625","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1750-1326-9-56","article-title":"Interleukin-1\u03b2 causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53","volume":"9","author":"Rossi","year":"2014","journal-title":"Mol. Neurodegener."},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.01.042_bb0630","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1046\/j.1471-4159.2003.01674.x","article-title":"Oligodendrocyte injury in multiple sclerosis: a role for p53","volume":"85","author":"Wosik","year":"2003","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.01.042_bb0635","doi-asserted-by":"crossref","DOI":"10.14336\/AD.2016.1120","article-title":"P53 dysfunction in neurodegenerative diseases - the cause or effect of pathological changes?","volume":"8","author":"Szybinska","year":"2017","journal-title":"Aging Dis."},{"key":"10.1016\/j.ijbiomac.2021.01.042_bb0640","doi-asserted-by":"crossref","first-page":"8966","DOI":"10.1038\/ncomms9966","article-title":"Nitric oxide mediates glial-induced neurodegeneration in Alexander disease","volume":"6","author":"Wang","year":"2015","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.01.042_bb0645","article-title":"Ginkgo biloba prevents oxidative stress-induced apoptosis blocking p53 activation in neuroblastoma cells","volume":"9","author":"Di Meo","year":"2020","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"10.1016\/j.ijbiomac.2021.01.042_bb0650","article-title":"Biological and therapeutic activities of thymoquinone: focus on the Nrf2 signaling pathway","author":"Talebi","year":"2020","journal-title":"Phytother. Res."},{"key":"10.1016\/j.ijbiomac.2021.01.042_bb0655","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2528935","article-title":"Modulation of hydrogen peroxide-induced oxidative stress in human neuronal cells by thymoquinone-rich fraction and thymoquinone via transcriptomic regulation of antioxidant and apoptotic signaling genes","volume":"2016","author":"Ismail","year":"2016","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"8","key":"10.1016\/j.ijbiomac.2021.01.042_bb0660","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.3923\/ijp.2018.1188.1197","article-title":"Anti-aging effects of ginseng and ginsenosides on the nervous system","volume":"14","author":"Lai","year":"2018","journal-title":"Int. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2021.01.042_bb0665","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jnutbio.2015.07.017","article-title":"Dietary flavonoid fisetin regulates aluminium chloride-induced neuronal apoptosis in cortex and hippocampus of mice brain","volume":"26","author":"Prakash","year":"2015","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.ijbiomac.2021.01.042_bb0670","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.neuroscience.2014.07.036","article-title":"Quercetin attenuates cell apoptosis of oxidant-stressed SK-N-MC cells while suppressing up-regulation of the defensive element, HIF-1\u03b1","volume":"277","author":"Roshanzamir","year":"2014","journal-title":"Neuroscience."},{"issue":"7","key":"10.1016\/j.ijbiomac.2021.01.042_bb0675","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22071122","article-title":"Protective effect of quercetin against oxidative stress-induced cytotoxicity in rat pheochromocytoma (PC-12) cells","volume":"22","author":"Bao","year":"2017","journal-title":"Molecules (Basel, Switzerland)"},{"key":"10.1016\/j.ijbiomac.2021.01.042_bb0680","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.brainres.2015.04.043","article-title":"Farnesol attenuates lipopolysaccharide-induced neurodegeneration in Swiss albino mice by regulating intrinsic apoptotic cascade","volume":"1620","author":"Santhanasabapathy","year":"2015","journal-title":"Brain Res."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014181302100060X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014181302100060X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T08:35:59Z","timestamp":1758875759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014181302100060X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":136,"alternative-id":["S014181302100060X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.01.042","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tantalizing role of p53 molecular pathways and its coherent medications in neurodegenerative diseases","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.01.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}